Jump to content
  • Volunteers

    volunteers.png

    We need volunteers. Could you seriously consider volunteering for the RRDi? The founder/director is appealing to millennials to think about helping others with rosacea through our non profit organization so we can keep this web site on the internet with its wealth of information on rosacea. If some don't step up to the plate and volunteer the RRDi may eventually close up shop. Seriously, do you want to see this organization cease?  The statistics globally show that volunteering is dropping (read this post). Then read below why you are needed. 

    If you would like to volunteer by simply joining our cause adding you name to our list and do nothing more that is the easiest way to volunteer. At the very least join the RRDi to increase our membership and if that is all you can do we understand and appreciate whatever you can do. Your email address is all we require to join. Our goal is to reach 10,000 members. 

    Volunteers are needed to recruit more members, for fund raising, public relations, writers to write posts on our member forum, editors for the newsletter, accounting/book keeping, webmasters, forum moderators, board members, researchers, and grant writers. If you have skill not mentioned, let us know. Why not suggest what you might volunteer to do when you join the RRDi, and in the application to become a corporate member there is a place to add a comment what your volunteer skills are. If you have questions, contact us. If you want to know what will do volunteering do for you, skip down to the subheading, What's in it for me below

    We would like to offer each author reimbursement if we publish the article in the next Journal of the RRDi.  If you want to volunteer to be on the publication team as an editor, author, proofreader, or any other job please join our cause and state in the comment box you want to join the Journal Publication Team.

    Volunteers are needed for the public relations committee or to write requests for donations to major corporations in our Funding Committee. Please join and mention you would like to help on the Funding Committee or for Public Relations. Or you can personally write a fund raiser letter using this sample letter.

    To Volunteer as a Writer please join. Check our announcements for special needs. Writers, editors, graphic artists and proof readers are needed! We have the ability to turn your post into an article. Why not post your article?

    Volunteer to write letters for donations by clicking here.

    Grant Writers are needed.

    What's In It For Me?

    There is scientific evidence that volunteering improves health and well being. For more information read this post

    Volunteers may receive a special Gmail account associated with the RRDi domain email which is a G Suite (formerly Google Apps) account associated with our domain, irosacea.org.

    gsuitelogo.png

    Google Apps Gmail

    You may receive the RRDi Newsletter by joining as a corporate member and requesting the newsletter by checking the box when you fill out the application. To know more about the Google apps account click here.

    You may receive on request a job referral with our letterhead if you volunteer for at least year to add to your resume or need a recommendation letter showing that you have regularly volunteered for our non profit organization. 

    Volunteers to POST comments in our member forum. 

    Volunteers Needed for the Following Jobs Immediately:

    Google AdWords Technician

    Google Analytics Technician

    Webmaster

    Forum Moderator

    Join the RRDi

    Mention which job you are volunteering for or create your own volunteer job and mention this in the appropriate box when applying.

    Another way help is by purchasing our Journal of the RRDi from Amazon or iUniverse which will help us continue its publication and may lead to some novel rosacea research. If you care to donate that would be appreciated.

  • Member Statistics

    • Total Members
      1,244
    • Most Online
      499

    Newest Member
    Paulie Paul
    Joined
  • Who's Online (See full list)

    There are no registered users currently online

  • Posts

    • Comparative effectiveness of purpuragenic 595 nm pulsed dye laser versus sequential emission of 595 nm pulsed dye laser and 1,064 nm Nd:YAG laser: a double-blind randomized controlled study. Acta Dermatovenerol Alp Pannonica Adriat. 2019 Mar;28(1):1-5 Authors: Campos MA, Sousa AC, Varela P, Baptista A, Menezes N Abstract INTRODUCTION: Erythematotelangiectatic rosacea is a common condition in Caucasians. The most frequently used lasers to treat this condition are pulsed dye laser (PDL) and neodymium:yttrium-aluminum-garnet laser (Nd:YAG). This study compares the treatment efficacy of purpuragenic PDL with that of sequential emission of 595 nm PDL and 1,064 nm Nd:YAG (multiplexed PDL/Nd:YAG). METHODS: We performed a prospective, randomized, and controlled split-face study. Both cheeks were treated, with side randomization to receive treatment with PDL or multiplexed PDL/Nd:YAG. Efficacy was evaluated by spectrophotometric measurement, visual photograph evaluation, the Dermatology Quality of Life Index questionnaire, and a post-treatment questionnaire. RESULTS: Twenty-seven patients completed the study. Treatment was associated with a statistically significant improvement in quality of life (p < 0.001). PDL and multiplexed PDL/Nd:YAG modalities significantly reduced the erythema index (EI; p < 0.05). When comparing the degree of EI reduction, no differences were observed between the two treatment modalities. PDL was associated with a higher degree of pain and a higher percentage of purpura. Multiplexed PDL/Nd:YAG modality was associated with fewer side effects and greater global satisfaction, and 96.3% of the patients would recommend this treatment to a friend. CONCLUSIONS: Both laser modalities are efficacious in the treatment of erythematotelangiectatic rosacea. The multiplexed PDL/Nd:YAG modality was preferred by the patients. PMID: 30901061 [PubMed - in process] {url} = URL to article
    • Logo of the Human Microbiome Project, a program of the NIH Common Fund, National Institutes of Health, image courtesy of Wikimedia Commons This subject of microbiome-based therapeutic strategies for rosacea is one of my favorite subjects which I have done a great deal of research on. You may want to read the latest article I have written on this subject of the human microbiome. 
    • Related Articles Skin diseases are more common than we think: screening results of an unreferred population at the Munich Oktoberfest. J Eur Acad Dermatol Venereol. 2019 Mar 19;: Authors: Tizek L, Schielein MC, Seifert F, Biedermann T, Böhner A, Zink A Abstract BACKGROUND: Skin diseases are ranked as the fourth most common cause of human illness, resulting in an enormous non-fatal burden. Despite this, many affected people do not consult a physician. Accordingly, the actual skin disease burden might be even higher since reported prevalence rates are typically based on secondary data that exclude individuals who do not seek medical care. OBJECTIVE: The aim of the study was to investigate the prevalence of skin diseases in an unreferred population in a real-life setting. METHODS: A cross-sectional study of 9 days duration was performed in 2016 at the 'Bavarian Central Agricultural Festival', which is part of the Munich Oktoberfest. As part of a public health check-up, screening examinations were performed randomly on participating visitors. All participants were 18 years or older and provided written informed consent. RESULTS: A total of 2701 individuals (53.5% women, 46.2% men; mean age 51.9 ± 15.3 years) participated in the study. At least one skin abnormality was observed in 1662 of the participants (64.5%). The most common diagnoses were actinic keratosis (26.6%), rosacea (25.5%) and eczema (11.7%). Skin diseases increased with age and were more frequent in men (72.3%) than in women (58.0%). Clinical examinations showed that nearly two-thirds of the affected participants were unaware of their abnormal skin findings. CONCLUSION: Skin diseases might be more common than previously estimated based on the secondary data of some sub-populations. Further information and awareness campaigns are needed to improve people's knowledge and reduce the global burden associated with skin diseases. PMID: 30891839 [PubMed - as supplied by publisher] {url} = URL to article
    • Fractionated Carbon Dioxide Laser Resurfacing as an Ideal Treatment Option for Severe Rhinophyma: A Case Report and Discussion. J Clin Aesthet Dermatol. 2019 Jan;12(1):24-27 Authors: Comeau V, Goodman M, Kober MM, Buckley C Abstract Rhinophyma is a progressive, disfiguring condition that affects the nose and is caused by the hypertrophy of sebaceous glands and connective tissue. Although its exact pathogenesis remains unclear, it is generally thought to be a subtype of the chronic, inflammatory condition rosacea. To date, oral and topical treatments have been largely ineffective at treating rhinophyma. Laser resurfacing is an emerging treatment modality that offers hope for patients with severe rhinophyma. We present a case of rhinophyma treated via fractionated carbon dioxide laser resurfacing with impressive results, excellent tolerability, and minimal downtime. PMID: 30881573 [PubMed] {url} = URL to article
    • Effective Treatment of Morbihan's Disease with Long-term Isotretinoin: A Report of Three Cases. J Clin Aesthet Dermatol. 2019 Jan;12(1):32-34 Authors: Olvera-Cortés V, Pulido-Díaz N Abstract Morbihan's disease is characterized by the presence of chronic and persistent edema of the periorbital tissue, forehead, glabella, nose, and cheeks. In some cases, it is related to acne and rosacea, but its exact etiology remains unknown. A defined therapeutic approach has yet to be established for the treatment of Morbihan's disease. To date, the systemic and surgical options attempted have not been very successful and/or do not yield sustained results. Isotretinoin is a key systemic treatment used for the treatment of various skin conditions. However, there are few reports of isotretinoin being used to treat Morbihan's disease. Here, we present the details of three patients with Morbihan's disease who were successfully treated long-term with isotretinoin. PMID: 30881575 [PubMed] {url} = URL to article
×
×
  • Create New...